In a rare rebuke, FDA refuses to fully review Aeglea’s rare disease drug application
In a rare rebuke, FDA refuses to fully review Aeglea’s [...]
UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks. Why not just buy it?
UPDATE: Bristol Myers triples-down on Immatics, bringing deal to $4.2B [...]
Centessa dumps top program after evidence of tolerability issues stunt market potential
Centessa dumps top program after evidence of tolerability issues stunt [...]
Oncology biotech Atreca pulled into industry’s layoff whirlpool, cuts 25% of staff
Oncology biotech Atreca pulled into industry’s layoff whirlpool, cuts 25% [...]
Enochian CEO, facing short-seller attack, tries to distance biotech from co-founder arrested in murder-for-hire-plot
Enochian CEO, facing short-seller attack, tries to distance biotech from [...]
PARADIGME shift: Nordic Nanovector reviews stuttering cancer trial as enrollment grinds to a halt
PARADIGME shift: Nordic Nanovector reviews stuttering cancer trial as enrollment [...]
Roche pays Repare $125M to join Big Pharma peers in cancer race
Roche pays Repare $125M to join Big Pharma peers in [...]
Merck KGaA nabs another baton in protein degradation race with $554M Proxygen deal
Merck KGaA nabs another baton in protein degradation race with [...]
Oncology trial starts hit record levels as COVID disruptions ease: report
Oncology trial starts hit record levels as COVID disruptions ease: [...]
Samantha Truex did a rare thing last time she was CEO: admit defeat. She’s back with a new biotech and $200M
Samantha Truex did a rare thing last time she was [...]